Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBr.small Co.2 Regulatory News (BSC)

Share Price Information for Br.small Co.2 (BSC)

Share Price is delayed by 15 minutes
Get Live Data
50.55    0.00 (0.00%)
Bid:
49.60
Ask:
51.50
Spread: 1.90 (3.831%)
Market Cap: £193.32m
BSC Live PriceLast checked at - London Stock Exchange

Intraday Br.small Co.2 Share Chart

Interim Management Statement

19 May 2009 13:36

RNS Number : 5073S
British SmallerTechCompaniesVCT2PLC
19 May 2009
Β 

ο»Ώ

BRITISH SMALLER TECHNOLOGY COMPANIES VCT 2 PLC ("the Company")

INTERIM MANAGEMENT STATEMENT

For the quarter ended 31 March 2009

British Smaller Technology Companies VCT 2 plc presents its interim management statement for the quarter ended 31 March 2009. This constitutes the Company's first interim management statement for the financial year ending 31 December 2009, as required by Rule 4.3 of the Disclosure and Transparency Rules. A copy of this interim management statement can be found at www.yfmgroup.co.uk.

The unaudited net asset value per Ordinary share as at 31 March 2009 wasΒ 75.7p (31 December 2008: 76.9p). The net asset valueΒ as at 31 March 2009Β is stated after taking account of theΒ thirdΒ interim dividend of 2.0p per Ordinary share in respect of the year ended 31 December 2008, which will be paid on 19 May 2009.

The total return at 31 March 2009, calculated by reference to the net asset value per share and the cumulative dividends paid and proposed, wasΒ 93.7p per share compared to 92.9p at 31 December 2008.

The number of Ordinary shares in issue at 31 March 2009 was 16,641,257. There were no shares purchased or issued by the Company during the quarter.

Net assets at 31 March 2009 comprised the following:

Β£000

% of net assets

Unquoted investments at fair value

6,493

51.5%

Quoted investment at bid price

1,178

9.4%

Gilt investments

4,313

34.2%

Total investments

11,984

95.1%

Cash and cash equivalents

634

5.0%

Other net current assetsΒ (liabilities)

(16)

(0.1%)

Net assets

12,602

100.0%

The ten largest investments by valuation at 31 March 2009 were as follows:

Β£000

% of net assets

Digital Healthcare Limited

2,112

16.8%

Silistix Limited

895Β 

7.1%

Immunobiology Limited

800Β 

6.3%

DxS Limited

792Β 

6.3%

Primal Pictures Limited

716Β 

5.7%

The ART Technology Group Inc

456Β 

3.6%

Pressure Technologies plc

350Β 

2.8%

Waterfall Services Limited

316Β 

2.5%

Ellfin Home Care Limited

312

2.4%

Harvey Jones Limited

247Β 

2.0%

Top ten investments

6,996

55.5%

Other investments

675

5.4%

Gilt investments

4,313

34.2%

Total investments

11,984

95.1%

Quoted investments are carried at bid price at 31 March 2009. Unquoted investment are carried at fair value as at 31 March 2009 as determined by the directors.

The movement in net asset value can be analysed as:Β 

PenceΒ 

per share

NAV at 31.12.08

76.9

Less Dividend

(2.0)Β 

Change in underlying NAV

0.8

NAV at 31.03.09

75.7

The totalΒ return, calculated by reference to the net asset value plus cumulative dividend paid and proposed has increased byΒ 0.8p toΒ 93.7p, cumulative dividends representing 18 pence per share, the equivalent of 19.2%.

The net asset value currently comprisesΒ 39% in cash and gilts and as such the Company is well placed to take advantage of selective investment opportunities as they arise.

19Β May 2009

For further information please contact:

David Hall YFM Private Equity Tel: 0161 832 7603

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
IMSGUUCWAUPBGPB
Date   Source Headline
13th Aug 20129:44 amRNSRealisation of Holding In Primal Pictures Limited
15th Jun 20127:00 amRNSTransaction in Own Shares
23rd May 201212:16 pmRNSIssue of Equity
14th May 20127:00 amRNSTransaction in Own Shares
11th May 20121:31 pmRNSAGM Statement
11th May 20127:00 amRNSInterim Management Statement
17th Apr 20128:50 amRNSIssue of Equity
10th Apr 201211:00 amRNSIssue of Equity
5th Apr 20127:00 amRNSIncrease of Offer Size
30th Mar 20124:21 pmRNSAnnual Financial Report
21st Mar 20127:00 amRNSIssue of Equity
5th Jan 20123:50 pmRNSIssue of Equity
20th Dec 20119:08 amRNSPurchase of Own Securities and Total Voting Rights
30th Nov 20113:14 pmRNSResult of General Meeting
28th Oct 20113:57 pmRNSPublication of Fundraising Circular
27th Oct 20114:09 pmRNSPublication of Fundraising Prospectus
24th Oct 20117:00 amRNSInterim Management Statement
21st Sep 20113:26 pmRNSPurchase of Own Securities and Total Voting Rights
8th Sep 20113:07 pmRNSIssue of Equity
30th Aug 20112:52 pmRNSResolution of Share Buy Back Scheme
23rd Aug 20114:22 pmRNSCompany Secretary Change
4th Aug 20114:03 pmRNSIssue of Equity
3rd Aug 20111:48 pmRNSHalf Yearly Report
3rd Aug 20111:36 pmRNSAuthorisation of Share buy Back Policy
10th Jun 201112:06 pmRNSIssue of Equity
19th May 201110:00 amRNSInterim Management Statement
16th May 20112:27 pmRNSAGM Statement
5th May 201111:44 amRNSIssue of Equity
7th Apr 20113:42 pmRNSCompany Secretary Change
6th Apr 20117:00 amRNSAllotment of Shares
4th Apr 201111:01 amRNSTransaction in Own Shares
1st Apr 20117:00 amRNSAnnual Financial Report
23rd Mar 20117:00 amRNSAllotment of Shares
11th Mar 20114:26 pmRNSOffer Update
11th Mar 20114:24 pmRNSOffer Update
12th Jan 20114:05 pmRNSResult of General Meeting
16th Dec 20104:35 pmRNSStatement re Total Voting Rights
13th Dec 20104:27 pmRNSTransaction in Own Shares
18th Nov 20104:15 pmRNSIssue of Equity and Close of 2010/11 Offers
17th Nov 20107:00 amRNSInterim Management Statement to 30 September 2010
5th Nov 20104:22 pmRNSTransaction in Own Shares
20th Oct 20101:57 pmRNSResult of General Meeting
20th Oct 20101:57 pmRNSResult of General Meeting
1st Oct 20107:00 amRNSChanges to the Board of Directors
27th Sep 20103:20 pmRNSDoc re. Circular and Half Yearly Report
22nd Sep 201012:33 pmRNSChanges to the Board of Directors
25th Aug 20104:02 pmRNSHalf Yearly Report to 30 June 2010
19th May 20102:57 pmRNSInterim Management Statement to 31 March 2010
13th May 20109:31 amRNSAGM Statement
4th May 20104:31 pmRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.